Literature DB >> 16104359

Radiation therapy in the management of thymic tumors.

Tony Y Eng1, Charles R Thomas.   

Abstract

Thymic tumors including thymomas, thymic carcinomas, and thymic carcinoid tumors, are relatively infrequent. These tumors with a wide spectrum of histological and biological features may exhibit an indolent clinical course (thymomas) or manifest an aggressive behavior (thymic carcinoma) with a high risk of relapse and metastasis. Successful management of these tumors depends on accurate diagnosis, thorough staging, proper assessment of patient health status, and selection of treatment modality. Surgery remains the mainstay of therapy whereas radiation therapy plays an important role in subtotally resected or unresectable cases. The risk of side effects and late sequelae is generally low when proper radiation technique is employed. This review examines the current role of radiation therapy in the management of these tumors.

Entities:  

Mesh:

Year:  2005        PMID: 16104359     DOI: 10.1053/j.semtcvs.2004.12.005

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  7 in total

1.  Thymoma with dissemination: efficacy of macroscopic total resection of disseminated nodules.

Authors:  Motoki Yano; Hidefumi Sasaki; Haruhiro Yukiue; Osamu Kawano; Katsuhiro Okuda; Yu Hikosaka; Yoshitaka Fujii
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

2.  Entire hemithorax irradiation for Masaoka stage IVa thymomas.

Authors:  André Soares; Luís Vasco Louro; Marta Almeida; Olga Sousa
Journal:  Rep Pract Oncol Radiother       Date:  2012-07-15

3.  Thymoma: Results of treatment and role of radiotherapy.

Authors:  Marcin Hetnał; Krzysztof Małecki; Magdalena Wolanin; Stanisław Korzeniowski; Tomasz Walasek
Journal:  Rep Pract Oncol Radiother       Date:  2010-02-18

4.  Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen.

Authors:  Francesco Perri; Salvatore Pisconti; Manuel Conson; Roberto Pacelli; Giuseppina Della Vittoria Scarpati; Antonio Gnoni; Carmine D'Aniello; Carla Cavaliere; Antonella Licchetta; Laura Cella; Mario Giuliano; Concetta Schiavone; Sara Falivene; Giuseppe Di Lorenzo; Carlo Buonerba; Vincenzo Ravo; Paolo Muto
Journal:  Onco Targets Ther       Date:  2015-06-08       Impact factor: 4.147

5.  Long-term follow-up and prognostic factors for advanced thymic carcinoma.

Authors:  Jun-xin Wu; Hui-qin Chen; Ling-dong Shao; Su-fang Qiu; Qian-yu Ni; Bu-hong Zheng; Jie-zhong Wang; Jian-ji Pan; Jin-luan Li
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  Optimal first-line treatment for advanced thymic carcinoma.

Authors:  Xue Yang; Minglei Zhuo; Anhui Shi; Shengnan Yang; Ziping Wang; Meina Wu; Tongtong An; Yuyan Wang; Jianjie Li; Jia Zhong; Hanxiao Chen; Bo Jia; Zhi Dong; Jun Zhao
Journal:  Thorac Cancer       Date:  2019-10-01       Impact factor: 3.500

Review 7.  Radiation dose for thymic tumours.

Authors:  Nafisha Lalani; Anthony M Brade
Journal:  Mediastinum       Date:  2020-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.